You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Single-Domain Antibody Platform Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

As per the International Federation of Pharmaceutical Manufacturers & Associations, out of the total expenditure on drug discovery, 25% is spent on preclinical testing. Implementation of single-domain antibodies for drug discovery saves money and shortens the very lengthy process, contributing to higher demand in the single-domain antibody platforms market.
Market Analysis and Insights: Global Single-Domain Antibody Platform Market
The global Single-Domain Antibody Platform market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Single-Domain Antibody Platform market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Single-Domain Antibody Platform market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Single-Domain Antibody Platform market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Single-Domain Antibody Platform market.
Single-Domain Antibody Platform Breakdown Data by Type
Multi-Specific Single Domain Antibody
Bispecific Single Domain Antibody
Multivalent Single Domain Antibody
Mono-Specific Single Domain Antibody
Single-Domain Antibody Platform Breakdown Data by Application
Diagnostic Laboratories
Clinical Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Based on regional and country-level analysis, the Single-Domain Antibody Platform market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Single-Domain Antibody Platform market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Creative BioLabs A
Synbio Technologies
ProSci Incorporated
BioCat GmbH
Antibody Design Labs
GenScript
Oak BioSciences, Inc.
Rockland Immunochemicals, Inc
Hybrigenics Services
NeoClone Biotechnology International LLC
Kaneka Eurogentec S.A
ProteoGenix
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single-Domain Antibody Platform Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Multi-Specific Single Domain Antibody
1.2.3 Bispecific Single Domain Antibody
1.2.4 Multivalent Single Domain Antibody
1.2.5 Mono-Specific Single Domain Antibody
1.3 Market by Application
1.3.1 Global Single-Domain Antibody Platform Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic Laboratories
1.3.3 Clinical Laboratories
1.3.4 Academic and Research Institutes
1.3.5 Pharmaceutical and Biotechnology Companies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Single-Domain Antibody Platform Market Perspective (2016-2027)
2.2 Single-Domain Antibody Platform Growth Trends by Regions
2.2.1 Single-Domain Antibody Platform Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Single-Domain Antibody Platform Historic Market Share by Regions (2016-2021)
2.2.3 Single-Domain Antibody Platform Forecasted Market Size by Regions (2022-2027)
2.3 Single-Domain Antibody Platform Industry Dynamic
2.3.1 Single-Domain Antibody Platform Market Trends
2.3.2 Single-Domain Antibody Platform Market Drivers
2.3.3 Single-Domain Antibody Platform Market Challenges
2.3.4 Single-Domain Antibody Platform Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Single-Domain Antibody Platform Players by Revenue
3.1.1 Global Top Single-Domain Antibody Platform Players by Revenue (2016-2021)
3.1.2 Global Single-Domain Antibody Platform Revenue Market Share by Players (2016-2021)
3.2 Global Single-Domain Antibody Platform Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Single-Domain Antibody Platform Revenue
3.4 Global Single-Domain Antibody Platform Market Concentration Ratio
3.4.1 Global Single-Domain Antibody Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single-Domain Antibody Platform Revenue in 2020
3.5 Single-Domain Antibody Platform Key Players Head office and Area Served
3.6 Key Players Single-Domain Antibody Platform Product Solution and Service
3.7 Date of Enter into Single-Domain Antibody Platform Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Single-Domain Antibody Platform Breakdown Data by Type
4.1 Global Single-Domain Antibody Platform Historic Market Size by Type (2016-2021)
4.2 Global Single-Domain Antibody Platform Forecasted Market Size by Type (2022-2027)

5 Single-Domain Antibody Platform Breakdown Data by Application
5.1 Global Single-Domain Antibody Platform Historic Market Size by Application (2016-2021)
5.2 Global Single-Domain Antibody Platform Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Single-Domain Antibody Platform Market Size (2016-2027)
6.2 North America Single-Domain Antibody Platform Market Size by Type
6.2.1 North America Single-Domain Antibody Platform Market Size by Type (2016-2021)
6.2.2 North America Single-Domain Antibody Platform Market Size by Type (2022-2027)
6.2.3 North America Single-Domain Antibody Platform Market Size by Type (2016-2027)
6.3 North America Single-Domain Antibody Platform Market Size by Application
6.3.1 North America Single-Domain Antibody Platform Market Size by Application (2016-2021)
6.3.2 North America Single-Domain Antibody Platform Market Size by Application (2022-2027)
6.3.3 North America Single-Domain Antibody Platform Market Size by Application (2016-2027)
6.4 North America Single-Domain Antibody Platform Market Size by Country
6.4.1 North America Single-Domain Antibody Platform Market Size by Country (2016-2021)
6.4.2 North America Single-Domain Antibody Platform Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Single-Domain Antibody Platform Market Size (2016-2027)
7.2 Europe Single-Domain Antibody Platform Market Size by Type
7.2.1 Europe Single-Domain Antibody Platform Market Size by Type (2016-2021)
7.2.2 Europe Single-Domain Antibody Platform Market Size by Type (2022-2027)
7.2.3 Europe Single-Domain Antibody Platform Market Size by Type (2016-2027)
7.3 Europe Single-Domain Antibody Platform Market Size by Application
7.3.1 Europe Single-Domain Antibody Platform Market Size by Application (2016-2021)
7.3.2 Europe Single-Domain Antibody Platform Market Size by Application (2022-2027)
7.3.3 Europe Single-Domain Antibody Platform Market Size by Application (2016-2027)
7.4 Europe Single-Domain Antibody Platform Market Size by Country
7.4.1 Europe Single-Domain Antibody Platform Market Size by Country (2016-2021)
7.4.2 Europe Single-Domain Antibody Platform Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Single-Domain Antibody Platform Market Size (2016-2027)
8.2 Asia-Pacific Single-Domain Antibody Platform Market Size by Type
8.2.1 Asia-Pacific Single-Domain Antibody Platform Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Single-Domain Antibody Platform Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Single-Domain Antibody Platform Market Size by Type (2016-2027)
8.3 Asia-Pacific Single-Domain Antibody Platform Market Size by Application
8.3.1 Asia-Pacific Single-Domain Antibody Platform Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Single-Domain Antibody Platform Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Single-Domain Antibody Platform Market Size by Application (2016-2027)
8.4 Asia-Pacific Single-Domain Antibody Platform Market Size by Region
8.4.1 Asia-Pacific Single-Domain Antibody Platform Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Single-Domain Antibody Platform Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Single-Domain Antibody Platform Market Size (2016-2027)
9.2 Latin America Single-Domain Antibody Platform Market Size by Type
9.2.1 Latin America Single-Domain Antibody Platform Market Size by Type (2016-2021)
9.2.2 Latin America Single-Domain Antibody Platform Market Size by Type (2022-2027)
9.2.3 Latin America Single-Domain Antibody Platform Market Size by Type (2016-2027)
9.3 Latin America Single-Domain Antibody Platform Market Size by Application
9.3.1 Latin America Single-Domain Antibody Platform Market Size by Application (2016-2021)
9.3.2 Latin America Single-Domain Antibody Platform Market Size by Application (2022-2027)
9.3.3 Latin America Single-Domain Antibody Platform Market Size by Application (2016-2027)
9.4 Latin America Single-Domain Antibody Platform Market Size by Country
9.4.1 Latin America Single-Domain Antibody Platform Market Size by Country (2016-2021)
9.4.2 Latin America Single-Domain Antibody Platform Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Single-Domain Antibody Platform Market Size (2016-2027)
10.2 Middle East & Africa Single-Domain Antibody Platform Market Size by Type
10.2.1 Middle East & Africa Single-Domain Antibody Platform Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Single-Domain Antibody Platform Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Single-Domain Antibody Platform Market Size by Type (2016-2027)
10.3 Middle East & Africa Single-Domain Antibody Platform Market Size by Application
10.3.1 Middle East & Africa Single-Domain Antibody Platform Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Single-Domain Antibody Platform Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Single-Domain Antibody Platform Market Size by Application (2016-2027)
10.4 Middle East & Africa Single-Domain Antibody Platform Market Size by Country
10.4.1 Middle East & Africa Single-Domain Antibody Platform Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Single-Domain Antibody Platform Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Creative BioLabs A
11.1.1 Creative BioLabs A Company Details
11.1.2 Creative BioLabs A Business Overview
11.1.3 Creative BioLabs A Single-Domain Antibody Platform Introduction
11.1.4 Creative BioLabs A Revenue in Single-Domain Antibody Platform Business (2016-2021)
11.1.5 Creative BioLabs A Recent Development
11.2 Synbio Technologies
11.2.1 Synbio Technologies Company Details
11.2.2 Synbio Technologies Business Overview
11.2.3 Synbio Technologies Single-Domain Antibody Platform Introduction
11.2.4 Synbio Technologies Revenue in Single-Domain Antibody Platform Business (2016-2021)
11.2.5 Synbio Technologies Recent Development
11.3 ProSci Incorporated
11.3.1 ProSci Incorporated Company Details
11.3.2 ProSci Incorporated Business Overview
11.3.3 ProSci Incorporated Single-Domain Antibody Platform Introduction
11.3.4 ProSci Incorporated Revenue in Single-Domain Antibody Platform Business (2016-2021)
11.3.5 ProSci Incorporated Recent Development
11.4 BioCat GmbH
11.4.1 BioCat GmbH Company Details
11.4.2 BioCat GmbH Business Overview
11.4.3 BioCat GmbH Single-Domain Antibody Platform Introduction
11.4.4 BioCat GmbH Revenue in Single-Domain Antibody Platform Business (2016-2021)
11.4.5 BioCat GmbH Recent Development
11.5 Antibody Design Labs
11.5.1 Antibody Design Labs Company Details
11.5.2 Antibody Design Labs Business Overview
11.5.3 Antibody Design Labs Single-Domain Antibody Platform Introduction
11.5.4 Antibody Design Labs Revenue in Single-Domain Antibody Platform Business (2016-2021)
11.5.5 Antibody Design Labs Recent Development
11.6 GenScript
11.6.1 GenScript Company Details
11.6.2 GenScript Business Overview
11.6.3 GenScript Single-Domain Antibody Platform Introduction
11.6.4 GenScript Revenue in Single-Domain Antibody Platform Business (2016-2021)
11.6.5 GenScript Recent Development
11.7 Oak BioSciences, Inc.
11.7.1 Oak BioSciences, Inc. Company Details
11.7.2 Oak BioSciences, Inc. Business Overview
11.7.3 Oak BioSciences, Inc. Single-Domain Antibody Platform Introduction
11.7.4 Oak BioSciences, Inc. Revenue in Single-Domain Antibody Platform Business (2016-2021)
11.7.5 Oak BioSciences, Inc. Recent Development
11.8 Rockland Immunochemicals, Inc
11.8.1 Rockland Immunochemicals, Inc Company Details
11.8.2 Rockland Immunochemicals, Inc Business Overview
11.8.3 Rockland Immunochemicals, Inc Single-Domain Antibody Platform Introduction
11.8.4 Rockland Immunochemicals, Inc Revenue in Single-Domain Antibody Platform Business (2016-2021)
11.8.5 Rockland Immunochemicals, Inc Recent Development
11.9 Hybrigenics Services
11.9.1 Hybrigenics Services Company Details
11.9.2 Hybrigenics Services Business Overview
11.9.3 Hybrigenics Services Single-Domain Antibody Platform Introduction
11.9.4 Hybrigenics Services Revenue in Single-Domain Antibody Platform Business (2016-2021)
11.9.5 Hybrigenics Services Recent Development
11.10 NeoClone Biotechnology International LLC
11.10.1 NeoClone Biotechnology International LLC Company Details
11.10.2 NeoClone Biotechnology International LLC Business Overview
11.10.3 NeoClone Biotechnology International LLC Single-Domain Antibody Platform Introduction
11.10.4 NeoClone Biotechnology International LLC Revenue in Single-Domain Antibody Platform Business (2016-2021)
11.10.5 NeoClone Biotechnology International LLC Recent Development
11.11 Kaneka Eurogentec S.A
11.11.1 Kaneka Eurogentec S.A Company Details
11.11.2 Kaneka Eurogentec S.A Business Overview
11.11.3 Kaneka Eurogentec S.A Single-Domain Antibody Platform Introduction
11.11.4 Kaneka Eurogentec S.A Revenue in Single-Domain Antibody Platform Business (2016-2021)
11.11.5 Kaneka Eurogentec S.A Recent Development
11.12 ProteoGenix
11.12.1 ProteoGenix Company Details
11.12.2 ProteoGenix Business Overview
11.12.3 ProteoGenix Single-Domain Antibody Platform Introduction
11.12.4 ProteoGenix Revenue in Single-Domain Antibody Platform Business (2016-2021)
11.12.5 ProteoGenix Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 101